Fuhrman grade and concomitant bisphosphonates as additional prognostic factors in metastatic renal cell carcinoma with bone metastases treated with sunitinib

被引：2
|
作者：
Beuselinck, B. L.
Medioni, J.
Wolter, P.
Blesius, A.
Karadimou, A.
Schbffski, P.
Escudier, B. J.
Zucman-Rossi, J.
Paridaens, R.
Oudard, S.
机构：
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Georges Pompidou European Hosp, Dept Med Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.388
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
388
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CHEMOTHERAPY
    Davidov, Deyan
    JOURNAL OF IMAB, 2016, 22 (01): : 1045 - 1049
  • [22] Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma
    Klatte, Tobias
    Anterasian, Christine
    Said, Jonathan W.
    de Martino, Michela
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF UROLOGY, 2010, 183 (06): : 2143 - 2147
  • [23] Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib
    Keizman, Daniel
    Sarid, David
    Lee, Jae L.
    Sella, Avishay
    Gottfried, Maya
    Hammers, Hans
    Eisenberger, Mario A.
    Carducci, Michael A.
    Sinibaldi, Victoria
    Neiman, Victoria
    Rosenbaum, Eli
    Peer, Avivit
    Neumann, Avivit
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Yildiz, Ibrahim
    ONCOLOGIST, 2016, 21 (10): : 1212 - 1217
  • [24] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Feldman, Darren R.
    Martorella, Andrew J.
    Robbins, Richard J.
    Motzer, Robert J.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 974 - 975
  • [25] Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
    Dogan, Izzet
    Iribas, Ayca
    Paksoy, Nail
    Ekenel, Meltem
    Vatansever, Sezai
    Basaran, Mert
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [26] A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
    Morizane, Shuichi
    Iwamoto, Hideto
    Yao, Akihisa
    Isoyama, Tadahiro
    Sejima, Takehiro
    Takenaka, Atsushi
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2012, 65 (04) : 227 - 229
  • [27] Unexpected hyperparathyroidism in metastatic renal cell carcinoma patients treated with sunitinib
    Mazzanti, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [28] Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib
    Neiman, V.
    Keizman, D.
    Sarid, D.
    Lee, J-L.
    Sella, A.
    Gottfried, M.
    Hammers, H.
    Eisenberger, M.
    Carducci, M.
    Sinibaldi, V.
    Rosenbaum, E.
    Peer, A.
    Neumann, A.
    Mermershtain, W.
    Rouvinov, K. R.
    Berger, R.
    Yildiz, I.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Garfield, David H.
    Hercbergs, Aleck
    Davis, Paul J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12): : 975 - 976
  • [30] Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma
    Yildiz, Ibrahim
    Varol, Umut
    Sen, Fatma
    Kilic, Leyla
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (07): : 654 - 656
12345